|
BASCOM-21405EP |
Repository of Lung Cancer Diagnostic Procedure Images |
|
COG-ACNS0831 |
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1-21 years |
|
COG-ALTE05N1 |
Umbrella Long-term Follow-up Protocol |
|
COG-ALTE07C1 |
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer |
|
COG-ANBL00B1 |
Neuroblastoma Biology Studies |
|
COG-AREN03B2 |
Renal Tumor Classification, Biology, and Banking Study |
|
NCI-VN-BRONCH |
Piloting a Virtual Navigation (VN) System for Bronchoscopic Tissue Sampling |
|
PSCI-15-094-C2 |
MATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion |
|
PSCI-15-094-E |
MATCH Treatment Subprotocol E: AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR |
|
PSCI-15-094-F |
MATCH Treatment Subprotocol F: Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements |
